Focus Stocks
Above Resistance - Bank of America
Published on Wednesday, 08 February 2012 09:00 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of Bank of America Corporation (NYSE:BAC) closed the trading session at $7.85 just above calculated resistance at $7.50 moving to what appears to be a new range, as this move will clearly raise the attention of momentum buyers.
Bank of America Corporation (NYSE:BAC) offers banking, investing, asset management, and other financial and risk-management products and services. The Company has a mortgage lending subsidiary, and an investment banking and securities brokerage subsidiary. Bank of America, the biggest U.S. lender, has a very extensive network of retail banking locations in the U.S. The Bank was founded in 1874 and its headquartered in Charlotte, NC.
Bank of America's stock was trading in a well defined range with support at $7.02 and resistance at $7.50, given that this range was broken traders will be closely monitoring the stock
Related Articles
- Stock Futures Higher ahead of Holiday Weekend. Stocks to Watch: ALXN, AAPL, BAC, FB, FRO, NDAQ, PAY
- Bank of America Enters Into Agreement to Sell Remaining Interest in Archstone
- Stocks Mixed amid Weak Data and European Hopes
- Bank of America to Report Second-Quarter Financial Results on July 18
- Bank of America’s Interactive Home Loan Planner Shines Light on the Mortgage Process
- Stock Futures Higher Despite European Woes. Stocks to Watch: AAPL, BAC, COST, FB, HPQ, NTAP, P, TIF
- Stocks End Flat after Recovering from Steep Losses
- Bank of America Reaches Milestone: 10 Million Mobile Banking Customers
- Bank of America to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
- Bank of America Announces Expiration and Final Results of Tender Offers for Certain Capital Securities
Related Partner Headlines
- Lehman Brothers To Acquire Remaining Stake In Archstone For $1.58B - Benzinga
- Bank of America Enters Into Agreement to Sell Remaining Interest in Archstone for $1.58B - Benzinga
- Break Up Big Banks, Readers Say - TheStreet.com
- U.S. Banks Post Best Earnings Since Meltdown - TheStreet.com
- 5 Bank Stocks Wilting Under the Summer Sun - TheStreet.com
- Executives Send Buy Signals on These 4 Stocks - TheStreet.com
- 3 A-Rated Bank Stocks - TheStreet.com
- Bank Of America Corporation (BAC): Today's Featured Banking Winner - TheStreet.com
- Bank of America: Financial Winner - TheStreet.com
- Diamond Foods 'White Knight' Could Be a Stalking Horse - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









